The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients

Publication date: Available online 24 June 2020Source: Clinics and Research in Hepatology and GastroenterologyAuthor(s): Coralie Cayron, Julie Guillermet-Guibert
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research